Company Filing History:
1 out of 2 
1 out of 2 
1 out of 282 
Years Active: 2024
Title: Tamas Rujan: Innovator in Cancer Detection
Introduction
Tamas Rujan is a notable inventor based in Oberweil, Switzerland. He has made significant contributions to the field of cancer detection through his innovative methods and technologies. His work focuses on the detection and management of certain cancers, particularly ovarian cancer.
Latest Patents
Rujan holds a patent for "Epigenetic markers and related methods and means for the detection and management of certain cancers." This invention relates to methods for determining the presence or absence of specific cancers in individuals. It utilizes the detection of methylated or unmethylated CpGs in cell-free DNA to provide diagnostic, prognostic, and predictive utilities for managing cancers, especially in women.
Career Highlights
Throughout his career, Tamas Rujan has worked with prominent companies in the genomics and biotechnology sectors. He has been associated with Eurofins Genomics Europe Sequencing GmbH and Genedata AG, where he has contributed to advancements in genomic sequencing and data analysis.
Collaborations
Rujan has collaborated with esteemed colleagues, including Martin Widschwendter and Allison Jones. These partnerships have further enhanced his research and development efforts in cancer detection technologies.
Conclusion
Tamas Rujan's innovative work in cancer detection exemplifies the impact of epigenetic research on medical diagnostics. His contributions continue to pave the way for advancements in the management of cancer, particularly ovarian cancer.